Neogenomics NEO
NASDAQ NEO
$19.11 -0.30 (-1.55%)
As of: Sep 22, 2026 · 10:51 AM EDT

Neogenomics (NEO) Current Deferred Revenue (2017 - 2026)

Neogenomics' (NEO) quarterly Current Deferred Revenue came in at $528000.0 in Q2 2026, down 65.42% on a YoY basis from $1.5 million in Q2 2025, and down 41.27% quarter-over-quarter from $899000.0 in Q1 2026.

Analysis

Neogenomics (NEO) Current Deferred Revenue (2017 - 2026) Analysis & Trends

Neogenomics (NEO) has reported Current Deferred Revenue for 10 consecutive years, with $528000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Deferred Revenue fell 65.42% year-over-year to $528000.0; the trailing twelve-month figure through Jun 2026 stood at $528000.0 (down 65.42% YoY), and the FY2025 full-year result was $1.2 million, up 66.04% from the prior year.
  • Current Deferred Revenue fell to $528000.0 in Q2 2026 per NEO's latest filing, from $899000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $7.6 million in Q4 2022 and bottomed at $528000.0 in Q2 2026.
  • Historically, Current Deferred Revenue has averaged $3.3 million across 5 years, with a median of $1.8 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue plunged 81.14% in 2024, then soared 111.47% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $7.6 million in 2022, then sank by 71.88% to $2.1 million in 2023, then plunged by 65.02% to $745000.0 in 2024, then soared by 66.04% to $1.2 million in 2025, then slumped by 57.32% to $528000.0 in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $528000.0, $899000.0, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 528,000.00
Mar 31, 2026 899,000.00
Dec 31, 2025 1.24 Mn
Sep 30, 2025 2.08 Mn
Jun 30, 2025 1.53 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 745,000.00
Sep 30, 2024 985,000.00
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 2.13 Mn
Sep 30, 2023 3.62 Mn
Jun 30, 2023 5.71 Mn
Mar 31, 2023 6.07 Mn
Dec 31, 2022 7.58 Mn
Sep 30, 2022 7.51 Mn
Jun 30, 2022 7.47 Mn
Mar 31, 2022 7.20 Mn
Dec 31, 2021 6.11 Mn
Sep 30, 2021 6.21 Mn
API Access

Neogenomics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NEO&period=max&api_key=YOUR_API_KEY